Literature DB >> 31995801

In vitro Evaluation of Linezolid and Doripenem Clearance with Different Hemofilters.

Toshihisa Hiraiwa1, Kazuhiro Moriyama2, Kana Matsumoto3, Yasuyo Shimomura1, Yu Kato1, Chizuru Yamashita1, Yoshitaka Hara1, Takahiro Kawaji1, Yasuyoshi Kurimoto1, Tomoyuki Nakamura1, Naohide Kuriyama1, Junpei Shibata1, Hidefumi Komura1, Kunihiko Morita3, Osamu Nishida1.   

Abstract

INTRODUCTION: Renal replacement therapy (RRT) is widely used in the treatment of septic acute kidney injury. However, little is known about how the adsorption properties of hemofilters used in RRT affect antibiotic concentration. Because a cytokine-adsorption membrane is frequently used in RRT, it is important to determine the antibiotic adsorption capacity of this membrane.
OBJECTIVE: The present study aimed to investigate the antibiotic adsorption capacity of different hemofilter membranes by in vitro experiments using 2 antibacterial agents (linezolid and doripenem).
METHODS: We performed experimental hemofiltration in vitro using polyacrylonitrile (AN69ST), polymethylmethacrylate (PMMA), and polysulfone (PS) hemofilters for 1,440 min. The test solution was a 1,000-mL substitution fluid containing 30 µg/mL linezolid and 120 µg/mL doripenem. We measured drug concentrations at the inlet, outlet, and filtrate ports of the hemofilters for 1,440 min and calculated the sieving coefficient (SC) and adsorption rate (Ra) of the drugs onto the hemofilters.
RESULTS: The amount of linezolid adsorbed onto AN69ST, PMMA, and PS membranes was decreased relative to that in the control group at 15 min (p < 0.05). However, no SC for linezolid was obtained thereafter. The Ra of linezolid onto AN69ST, PMMA, and PS membranes was higher than that in the control group (p < 0.05). In contrast, no significant differences were observed in the concentrations and Ra values of doripenem adsorbed onto AN69ST, PMMA, and PS membranes compared with those in the control group.
CONCLUSIONS: Doripenem was not adsorbed onto PMMA, PS, and AN69ST membranes. Linezolid was adsorbed onto PMMA, PS, and AN69ST membranes, but only temporarily, and this did not affect drug bioavailability. The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Adsorption; Doripenem; Experimental model; Hemofilter; Linezolid

Mesh:

Substances:

Year:  2020        PMID: 31995801      PMCID: PMC7212696          DOI: 10.1159/000504039

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  27 in total

Review 1.  Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage.

Authors:  J Böhler; J Donauer; F Keller
Journal:  Kidney Int Suppl       Date:  1999-11       Impact factor: 10.545

Review 2.  Principles of antibacterial dosing in continuous renal replacement therapy.

Authors:  Gordon Choi; Charles D Gomersall; Qi Tian; Gavin M Joynt; Alexander M M Y Li; Jeffrey Lipman
Journal:  Blood Purif       Date:  2010-10-06       Impact factor: 2.614

Review 3.  Continuous hemodialfiltration using PMMA membrane: clinical efficacy and its mechanisms.

Authors:  K Moriyama; Y Soejima
Journal:  Contrib Nephrol       Date:  1999       Impact factor: 1.580

Review 4.  AN69: Evolution of the world's first high permeability membrane.

Authors:  Michel Thomas; Kazuhiro Moriyama; Ingrid Ledebo
Journal:  Contrib Nephrol       Date:  2011-08-08       Impact factor: 1.580

5.  Clearance of linezolid via continuous venovenous hemodiafiltration.

Authors:  Laurie S Mauro; Charles A Peloquin; Kimberly Schmude; Ragheb Assaly; Deepak Malhotra
Journal:  Am J Kidney Dis       Date:  2006-06       Impact factor: 8.860

6.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuk Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Intensive Care Med       Date:  2017-01-18       Impact factor: 17.440

7.  A simple, isocratic high-performance liquid chromatography assay for linezolid in human serum.

Authors:  C M Tobin; J Sunderland; L O White; A P MacGowan
Journal:  J Antimicrob Chemother       Date:  2001-11       Impact factor: 5.790

8.  Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.

Authors:  Lucie Seyler; Frédéric Cotton; Fabio Silvio Taccone; Daniel De Backer; Pascale Macours; Jean-Louis Vincent; Frédérique Jacobs
Journal:  Crit Care       Date:  2011-06-06       Impact factor: 9.097

Review 9.  Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review.

Authors:  Gianluca Villa; Paola Di Maggio; A Raffaele De Gaudio; Andrea Novelli; Riccardo Antoniotti; Enrico Fiaccadori; Chiara Adembri
Journal:  Crit Care       Date:  2016-11-19       Impact factor: 9.097

10.  Cyst infection in autosomal dominant polycystic kidney disease: penetration of meropenem into infected cysts.

Authors:  Satoshi Hamanoue; Tatsuya Suwabe; Yoshifumi Ubara; Koichi Kikuchi; Ryo Hazue; Koki Mise; Toshiharu Ueno; Kenmei Takaichi; Kana Matsumoto; Kunihiko Morita
Journal:  BMC Nephrol       Date:  2018-10-19       Impact factor: 2.388

View more
  1 in total

Review 1.  Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.

Authors:  Lu Li; Xin Li; Yanzhe Xia; Yanqi Chu; Haili Zhong; Jia Li; Pei Liang; Yishan Bu; Rui Zhao; Yun Liao; Ping Yang; Xiaoyang Lu; Saiping Jiang
Journal:  Front Pharmacol       Date:  2020-05-29       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.